SANUWAVE
Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to
Present Q2 Financial Results
EDEN
PRAIRIE, MN -- August 8, 2024 -- InvestorsHub NewsWire -- SANUWAVE
Health, Inc. (the "Company" or "SANUWAVE") (OTCQB:
SNWV), a leading provider of next-generation FDA-approved wound
care products, will host a live conference call on Tuesday, August
13, 2024, at 8:30 AM (ET) to present the Q2 2024 financial
results.
Telephone access to the call will be available by
dialing the following numbers:
Participant Dial-in
Information
Toll Free:
1-800-579-2543
Toll/International:
1-785-424-1789
Conference ID:
SANUWAVE
OR
click the link for instant telephone access to the
event.
https://viavid.webcasts.com/starthere.jsp?ei=1684060&tp_key=35ff7216a3
Materials for the conference call will be included
on the Company's website at www.sanuwave.com/investors.
A
replay will be made available through September 3, 2024:
Toll-Free: 1-844-512-2921 or
1-412-317-6671
Replay
Access ID: 11156749
About SANUWAVE
SANUWAVE Health is focused on the research,
development, and commercialization of its patented, non-invasive
and biological response-activating medical systems for the repair
and regeneration of skin, musculoskeletal tissue, and vascular
structures.
SANUWAVE's end-to-end wound care portfolio of
regenerative medicine products and product candidates help restore
the body's normal healing processes. SANUWAVE applies and
researches its patented energy transfer technologies in wound
healing, orthopedic/spine, aesthetic/cosmetic, and
cardiac/endovascular conditions.
Forward-Looking
Statements
This press release may contain
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995, such as statements
relating to future financial results, production expectations and
constraints, and plans for future business development activities.
Forward-looking statements include all statements that are not
statements of historical fact regarding intent, belief or current
expectations of the Company, its directors or its officers.
Investors are cautioned that any such forward-looking statements
are not guarantees of future performance and involve risks and
uncertainties, many of which are beyond the Company's ability to
control. Actual results may differ materially from those projected
in the forward-looking statements. Among the key risks, assumptions
and factors that may affect operating results, performance and
financial condition are risks associated with supply chain and
production constraints, regulatory oversight, the Company's ability
to manage its capital resource issues, competition, and the other
factors discussed in detail in the Company's periodic filings with
the Securities and Exchange Commission. The Company undertakes no
obligation to update any forward-looking statement.
Contact:
investors@sanuwave.com